Unresectable Locally Advanced
1 clinical trials · Condition
◉ Watch Unresectable Locally Advanced
| Record | Firm | Date |
|---|---|---|
| Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic Ductal Adenocarcinoma (NCT07627711) | Beijing Biotech | 2026-03-02 |
Track Unresectable Locally Advanced automatically
Every clearance here is in the API, with alerts when new ones post.